278 related articles for article (PubMed ID: 35229306)
1. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
[TBL] [Abstract][Full Text] [Related]
2. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract][Full Text] [Related]
3. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
Barczyński M; Konturek A; Stopa M; Nowak W
Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
[TBL] [Abstract][Full Text] [Related]
5. Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma.
Zhou M; Duan Y; Ye B; Wang Y; Li H; Wu Y; Chen P; Zhu J; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2022; 13():914946. PubMed ID: 35923627
[TBL] [Abstract][Full Text] [Related]
6. Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
Yu ST; Ge JN; Sun BH; Wei ZG; Xiao ZZ; Zhang ZC; Chen WS; Li TT; Lei ST
Oral Oncol; 2021 Dec; 123():105567. PubMed ID: 34710736
[TBL] [Abstract][Full Text] [Related]
7. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
8. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
[TBL] [Abstract][Full Text] [Related]
9. The importance of sentinel lymph node diagnostic biopsy from the lateral neck compartment in the surgical treatment of papillary thyroid cance.
Arciniegas LM; Reken V; Nemergut S; Sabol M; Durdik S; Kralik R
Bratisl Lek Listy; 2023; 124(11):827-832. PubMed ID: 37874805
[TBL] [Abstract][Full Text] [Related]
10. In Reference to: How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
Megwalu UC
Laryngoscope; 2023 Mar; 133(3):E21. PubMed ID: 36271915
[No Abstract] [Full Text] [Related]
11. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
[TBL] [Abstract][Full Text] [Related]
13. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
14. Clinical Efficacy of Intraoperative Ultrasound for Prophylactic Lymphadenectomy of the Lateral Cervical Neck in Stage CN0 Papillary Thyroid Cancer: A Prospective Study.
Shen Y; Li X; Tao L; Chen Y; Xie R
J Invest Surg; 2023 Dec; 36(1):2154416. PubMed ID: 36519315
[No Abstract] [Full Text] [Related]
15. Lymph Node Dissection for Papillary Thyroid Carcinoma.
Lo CY
Methods Mol Biol; 2022; 2534():57-78. PubMed ID: 35670968
[TBL] [Abstract][Full Text] [Related]
16. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
17. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS
World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
Kang JG; Choi JE; Kang SH
World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
[TBL] [Abstract][Full Text] [Related]
19. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
